Literature DB >> 25397825

Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder.

Charles C Engel1, Elizabeth H Cordova, David M Benedek, Xian Liu, Kristie L Gore, Christine Goertz, Michael C Freed, Cindy Crawford, Wayne B Jonas, Robert J Ursano.   

Abstract

BACKGROUND: Initial posttraumatic stress disorder (PTSD) care is often delayed and many with PTSD go untreated. Acupuncture appears to be a safe, potentially nonstigmatizing treatment that reduces symptoms of anxiety, depression, and chronic pain, but little is known about its effect on PTSD.
METHODS: Fifty-five service members meeting research diagnostic criteria for PTSD were randomized to usual PTSD care (UPC) plus eight 60-minute sessions of acupuncture conducted twice weekly or to UPC alone. Outcomes were assessed at baseline and 4, 8, and 12 weeks postrandomization. The primary study outcomes were difference in PTSD symptom improvement on the PTSD Checklist (PCL) and the Clinician-administered PTSD Scale (CAPS) from baseline to 12-week follow-up between the 2 treatment groups. Secondary outcomes were depression, pain severity, and mental and physical health functioning. Mixed model regression and t test analyses were applied to the data.
RESULTS: Mean improvement in PTSD severity was significantly greater among those receiving acupuncture than in those receiving UPC (PCLΔ=19.8±13.3 vs. 9.7±12.9, P<0.001; CAPSΔ=35.0±20.26 vs. 10.9±20.8, P<0.0001). Acupuncture was also associated with significantly greater improvements in depression, pain, and physical and mental health functioning. Pre-post effect-sizes for these outcomes were large and robust.
CONCLUSIONS: Acupuncture was effective for reducing PTSD symptoms. Limitations included small sample size and inability to parse specific treatment mechanisms. Larger multisite trials with longer follow-up, comparisons to standard PTSD treatments, and assessments of treatment acceptability are needed. Acupuncture is a novel therapeutic option that may help to improve population reach of PTSD treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25397825     DOI: 10.1097/MLR.0000000000000237

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

Review 1.  Complementary and alternative medicine approaches in the treatment of PTSD.

Authors:  Gary H Wynn
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

2.  The Manual Stimulation of Acupuncture Points in the Treatment of Post-Traumatic Stress Disorder: A Review of Clinical Emotional Freedom Techniques.

Authors:  Dawson Church; David Feinstein
Journal:  Med Acupunct       Date:  2017-08-01

3.  Association of Complementary and Alternative Therapies With Mental Health Outcomes in Pregnant Women Living in a Postdisaster Recovery Environment.

Authors:  Veronica Barcelona de Mendoza; Emily Harville; Jane Savage; Gloria Giarratano
Journal:  J Holist Nurs       Date:  2015-10-26

4.  Scanning the global literature.

Authors: 
Journal:  Glob Adv Health Med       Date:  2015-03

Review 5.  Do adjuvant interventions improve treatment outcome in adult patients with posttraumatic stress disorder receiving trauma-focused psychotherapy? A systematic review.

Authors:  Tanja Michael; Christian G Schanz; Hannah K Mattheus; Tobias Issler; Ulrich Frommberger; Volker Köllner; Monika Equit
Journal:  Eur J Psychotraumatol       Date:  2019-07-24

6.  A Randomized Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated with Traumatic Brain Injury.

Authors:  Wayne B Jonas; Dawn M Bellanti; Charmagne F Paat; Courtney C Boyd; Alaine Duncan; Ashley Price; Weimin Zhang; Louis M French; Heechin Chae
Journal:  Med Acupunct       Date:  2016-06-01

7.  Effects of Electroacupuncture on Sleep via the Dopamine System of the HPA Axis in Rats after Cage Change.

Authors:  Chen Xie; Jing Wang; Na Zhao; Wenjia Yang; Xiaolin Gao; Zhen Liu; Xinyu Chen; Chaojun Fang; Cong Fu; Yunfei Chen; Xintong Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-01       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.